Dog Vaccine Market Size - By Vaccine Type (Live Attenuated, Inactivated, Recombinant), Disease Type (Canine Distemper, CIRDC, Leptospirosis, Parvovirus, Rabies), Route of Administration (Injectable, Intranasal, Oral), End-use & Forecast, 2024 – 2032

Dog Vaccine Market Size - By Vaccine Type (Live Attenuated, Inactivated, Recombinant), Disease Type (Canine Distemper, CIRDC, Leptospirosis, Parvovirus, Rabies), Route of Administration (Injectable, Intranasal, Oral), End-use & Forecast, 2024 – 2032

Dog Vaccine Market size is anticipated to grow at 5.8% CAGR between 2024 and 2032 driven by the increasing awareness of pet health and the rising adoption of dogs as household pets. With pet owners becoming more informed about the importance of preventative healthcare for their animals, there is growing demand for vaccines that protect against various diseases, including rabies, distemper, and parvovirus. For instance, in February 2024, in partnership with several Animal Welfare Organizations, the Veterinary Health Department of the BMC initiated a comprehensive mass anti-rabies vaccination campaign.

Innovations, such as combination vaccines that protect against multiple diseases with a single shot, as well as the introduction of vaccines with longer-lasting effects, are enhancing the effectiveness and convenience of vaccination programs. The increasing focus on preventive care, supported by both veterinary clinics and pet insurance providers, will also contribute to the market expansion.

The overall industry is segmented into vaccine type, disease type, route of administration, end-use, and region.

Based on vaccine type, the dog vaccine market size from the inactivated vaccines segment is poised to grow between 2024 and 2032 due to their safety profile and effectiveness in providing robust immunity against various diseases. Inactivated vaccines are known for their ability to induce a strong and lasting immune response without the risk of causing the disease in the vaccinated dogs, further adding to the segment growth.

With respect to disease type, the dog vaccine market from the canine rabies segment is set to witness significant CAGR from 2024 to 2032. This is owing to the critical importance of rabies vaccination in preventing a fatal disease that poses significant health risks to both pets and humans. The high efficacy of rabies vaccines in preventing this deadly disease, coupled with the increasing awareness and regulatory requirements for pet vaccination will drive the strong demand for canine rabies vaccines.

Asia Pacific dog vaccine industry value is expected to witness notable growth from 2024 to 2032. Rapid urbanization and the growing middle-class population in countries like China and India are leading to the higher number of households with dogs, who are increasingly viewed as family members requiring proper medical care. The enhanced veterinary infrastructure and the expansion of veterinary services, including vaccination programs, are also improving the access to dog vaccines in the region.